Industry

Global Medical Device Security Market Report to 2031 – by Component, Security Type, Device Type, Deployment Mode, End User and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Medical Device Security Market 2021-2031: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The global medical device security market will reach $ 18,526.3 million by 2031, growing by 11.2% annually over 2021-2031, driven by the growing demand for connected medical devices due to the aging population and the … [Read more…]

Dr Karin Schmitt joins Mursla as Chief Operating Officer

Mursla adds seasoned executive with a wealth of experience in rapid growth and product commercialisation to leadership team CAMBRIDGE, England–(BUSINESS WIRE)–#Cambridge–Mursla, a novel multi-omics exosome characterisation company, is delighted to announce the appointment of Karin Schmitt, PhD as Chief Operating Officer. A highly respected life science executive, Karin has almost three decades of international experience … [Read more…]

King Faisal Specialist Hospital & Research Centre to Power Genomic Interpretation with VarSome

RIYADH, Kingdom of Saudi Arabia–(BUSINESS WIRE)–#genomics–King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics programs. The integration aligns with Saudi Arabia’s Vision 2030 to strengthen the Kingdom’s healthcare sector and its services with technological advancements. KFSH&RC is a leading tertiary … [Read more…]

Cleara Biotech Raises $2.5 Million in Seed Financing to Advance FOXO4-Therapeutics Pipeline for Treating Cancer and Chronic Diseases

Company Also Appoints Seasoned Industry Executive, Dr. Angelos Stergiou, as Board of Directors Chairman in Advance of Lead Program Entering the Clinic UTRECHT, Netherlands–(BUSINESS WIRE)–CLEARA Biotech B.V. (“Cleara” or the “Company”), a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different pathologies of “scarred cellular” senescence, including late-stage cancer and chronic diseases, … [Read more…]

Raghu Krishnan Named Johnson & Johnson’s New Consumer Health Area Managing Director for Africa, Middle East, and Turkey

Replacing Makis Kosmatos, Raghu Krishnan will spearhead all areas of Johnson & Johnson’s Consumer health strategic development across the area DUBAI–(BUSINESS WIRE)–Johnson & Johnson Consumer Health, are pleased to announce the appointment of Raghu Krishnan as the new Area Managing Director for AMET (Africa, Middle East, and Turkey), effective September 1st, 2022. Raghu Krishnan is … [Read more…]

Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, announced that it has entered into a Commitment Letter with certain funds managed by Highbridge Capital Management, LLC (“Highbridge”), pursuant to which Highbridge has committed to provide a … [Read more…]

Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the pricing of a follow-on public offering of 12,905,000 of its ordinary shares at a public offering price of $1.55 per share for aggregate gross proceeds … [Read more…]

Biocytogen to Present at BioJapan2022, Introducing Innovative R&D Platforms, Bispecific ADC Programs and Pipeline Progress

BEIJING–(BUSINESS WIRE)–#ADC–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will host a seminar at the BioJapan2022 Conference on Friday, October 14. The seminar, consisting of 3 modules, will introduce: Five RenMiceTM-based fully human antibody discovery platforms: RenMabTM-based monoclonal antibody platform, RenLite®-based bispecific antibody and bispecific ADC platforms, TCR-mimic platform, and GPCR platform Progress of Project … [Read more…]

Henry Ford Health and Acadia Healthcare Break Ground on New Behavioral Health Hospital

Work begins on modern inpatient behavioral health treatment and education facility in Metro Detroit, slated to open in 2024 WEST BLOOMFIELD, Mich.–(BUSINESS WIRE)–Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, broke ground today on a state-of-the-art behavioral health treatment and … [Read more…]

Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers

Approval also marks the second NGS-based companion diagnostic to identify RET-fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC) CARLSBAD, Calif.–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET-fusion positive … [Read more…]